Codexis, Inc. is a leading company in the chemicals industry based in the United States. With a high-risk rating score of 38.4, Codexis specializes in providing enzyme optimization services and developing biocatalyst products through its innovative CodeEvolver directed evolution technology platform. The company generates revenue primarily through product sales and licenses its technology to pharmaceutical companies worldwide. Overall, Codexis is at the forefront of ESG initiatives, focusing on environmental sustainability and governance in the chemicals sector.